Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

RECOMBIANT IMMUNOTOXINS TARGETED TO CD-22 BEARING CELLS AND TUMORS

  • Read more about RECOMBIANT IMMUNOTOXINS TARGETED TO CD-22 BEARING CELLS AND TUMORS
US Patent 7,541,034
Filed on 1999-09-20

Transgenically Produced Fusion Proteins

  • Read more about Transgenically Produced Fusion Proteins
US Application 09/398,610
Filed on 1999-09-17

PTERIDINE NUCLEOTIDE ANALOGS

  • Read more about PTERIDINE NUCLEOTIDE ANALOGS
Patent Cooperation Treaty
PCT/US1999/020541
Filed on 1999-09-07

NITRIC OXIDE Releasing Metallic Medical Devices

  • Read more about NITRIC OXIDE Releasing Metallic Medical Devices
US Patent 6,270,779
Filed on 2000-05-10

RETROVIRUS VECTORS DERIVED FROM AVIAN SARCOMA LEUKOSIS VIRUSES PERMITTING TRANSFER OF GENES INTO MAMMALIAN CELLS AND THERAPEUTIC...

  • Read more about RETROVIRUS VECTORS DERIVED FROM AVIAN SARCOMA LEUKOSIS VIRUSES PERMITTING TRANSFER OF GENES INTO MAMMALIAN CELLS AND THERAPEUTIC...
US Application 09/518,803
Filed on 2000-03-03

IDENTIFYING AND USING COMPOUNDS THAT INACTIVATE HIV-1 AND OTHER RETROVIRUSES BY ATTACKING HIGHLY CONSERVED ZINC FINGERS IN THE VIRAL NUCLEOCAPSID PROTEIN

  • Read more about IDENTIFYING AND USING COMPOUNDS THAT INACTIVATE HIV-1 AND OTHER RETROVIRUSES BY ATTACKING HIGHLY CONSERVED ZINC FINGERS IN THE VIRAL NUCLEOCAPSID PROTEIN
US Patent 6,989,263
Filed on 1999-11-01

METHODS AND COMPOSITIONS FOR DRM, A NUCLEAR PROTEIN WITH CELL CYCLE REGULATING ACTIVITY

  • Read more about METHODS AND COMPOSITIONS FOR DRM, A NUCLEAR PROTEIN WITH CELL CYCLE REGULATING ACTIVITY
US Application 09/444,066
Filed on 1999-11-19

Methods of Inhibiting the HGF-Met-uPA-Plasmin Network

  • Read more about Methods of Inhibiting the HGF-Met-uPA-Plasmin Network
Patent Cooperation Treaty
PCT/US00/03310
Filed on 2000-02-08

Lentivirus Vector System

  • Read more about Lentivirus Vector System
Patent Cooperation Treaty
PCT/US00/00390
Filed on 2000-01-06

A Chimeric Protein Comprising Non-Toxic Pseudomonas Exotoxin A and Type IV Pilin Sequences

  • Read more about A Chimeric Protein Comprising Non-Toxic Pseudomonas Exotoxin A and Type IV Pilin Sequences
US Patent 7,314,625
Filed on 2003-05-21

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1510
  • Page 1511
  • Page 1512
  • Page 1513
  • Page 1514
  • Page 1515
  • Page 1516
  • Page 1517
  • Page 1518
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health